Tracking immune changes to predict ovarian cancer return
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how changes in your immune system's T-cells (measured from blood samples) can help predict if ovarian cancer comes back. If you are newly diagnosed with advanced ovarian cancer and planning standard treatments (surgery plus chemo), you may join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old and newly diagnosed with advanced ovarian cancer (stage III or IV).
- You must be getting surgery to remove the tumor, followed by chemotherapy with paclitaxel and carboplatin (or similar drugs).
- You need to be in good enough health to be up and about (ECOG score 0 or 1).
- You must not have had chemotherapy before your surgery.
- You cannot have had your spleen removed or have serious health issues like active infections, bleeding disorders, or immune problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune-related markers in people with ovarian cancer to see if they can help predict prognosis (how the cancer may behave). If you qualify, your doctors may use your immune test results alongside other standard treatments like surgery, chemotherapy, and/or immunotherapy.
This study looks at how the immune system works in people with epithelial ovarian cancer. It aims to understand the immune landscape around the tumor, which could lead to better treatments in the future.
This trial tests a personalized vaccine for people with epithelial ovarian cancer who still have a small amount of cancer DNA in their blood after surgery. The goal is to see if the vaccine can help stop the cancer from coming back.
This study uses whole-body scans to look at how active tumors are in women with suspected ovarian cancer. The goal is to see if these scans can predict how well treatment will work, which may help personalize care.
This trial tests a new approach using your own immune cells (tumor-infiltrating lymphocytes) that have been modified to work better, followed by a combination of oral chemo and immunotherapy. It's for people with ovarian cancer that has come back after standard treatment.
This study looks at how your immune system behaves around the time of planned surgery for certain breast or ovarian cancers. It may help researchers understand what immune changes happen and how they relate to your cancer.
Hear when a new Epithelial Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.